Sir, The situation regarding antimicrobial resistance in bacteria from food-producing animals in Norway is, in an international perspective, favourable. The resistance frequencies are moderate and the situation has been stable since the start of the Norwegian monitoring programme in the veterinary sector (NORM-VET) (www. vetinst.no) in the year 2000. We report the first bacterial isolate of animal origin detected in Norway with reduced susceptibility to cephalosporins. The isolate (Escherichia coli 2006-01-1248, hereafter termed E. coli 1248) originated from a broiler domesticated in a cephalosporin-free environment and was included in the NORM-VET 2006 programme. MICs of cefotaxime, ceftiofur and ampicillin were 1, 4 and .32 mg/L, respectively. The cefotaxime MIC of 1 mg/L is close to the clinical breakpoint recommended by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) (susceptible 1 mg/L, resistant .2 mg/L). However, this value is considerably higher than those observed for susceptible E. coli strains (wild-type population) having MICs of 0.25 mg/L (www.eucast.org). MICs of cefalotin, ceftazidime and cefepime, determined using Etest w (AB Biodisk, Solna, Sweden) with E. coli ATCC 25922 as susceptible control, were 64, 0.5 and 0.25 mg/L, respectively. E. coli 1248 was positive in the double-disc synergy test and in the confirmatory test. The tests were carried out as recommended by the manufacturer using discs containing cefotaxime (30 mg), ceftriaxone (30 mg), ceftazidime (30 mg), cefepime (30 mg), amoxicillin/clavulanic acid (30 mg/15 mg), and ceftazidime and cefepime with and without clavulanic acid (Rosco, Taastrup, Denmark) (User's guide NEO-SENSITABS TM susceptibility testing 19th Edn, www.rosco.dk).
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PCR was performed for the detection of bla CTX-M, bla SHV and bla TEM 1,2 using the following control strains: E. coli K4-23 (bla CTX-M-9 ), E. coli Dak2 (bla SHV ) and E. coli 76-33094-7 (bla TEM ). Amplicons were produced with the bla TEM -specific primers only. Sequencing showed that a bla TEM-20 gene variant 3 was present. Conjugation showed that bla TEM-20 was located on a self-transferable plasmid. The transconjugant had the following MICs of b-lactams: ampicillin, .32 mg/L; cefotaxime, 0.5 mg/L; and ceftiofur, 1 mg/L.
The bla TEM-20 sequence contained three silent mutations at positions 346, 682 and 925 when compared with a previously published sequence (accession number Y17581). 3 The other bla TEM-20 gene variant, conferring high-level resistance to thirdgeneration cephalosporins, showed a 135 bp deletion in the promoter and a G!T mutation at position 162. These mutations were not identified in the sequence from E. coli 1248, and this may explain the lower MICs exhibited.
The bla TEM-20 gene has previously been detected in Salmonella Paratyphi B dT þ from poultry in the Netherlands. 2 The strain Salmonella Paratyphi B dT þ 63.48, kindly donated to us for further investigation, was compared with E. coli 1248. The bla TEM-20 gene was also carried by a conjugative plasmid in the Salmonella Paratyphi B dT þ strain, and the two bla TEM-20 sequences were 100% identical. The transconjugant was resistant to b-lactams only with the same MICs as the E. coli 1248 transconjugant. Both bla TEM-20 plasmids were assigned to the incompatibility (Inc) group I1 by PCR-based replicon typing. 4 Plasmid multilocus sequence typing (pMLST) for subtyping IncI1 plasmids was applied to the bla TEM-20 plasmids. 5 The following alleles (accession numbers) were obtained: repI1-1 (EU370458), ardA-2 (EU370453), trbA-pndC-2 (EU40466), sogS-3 (EU70463) and pilL-3 (EU370457). These alleles corresponded to sequence type 5, previously assigned to an IncI1 plasmid carrying bla TEM-52 identified in a Salmonella Infantis strain isolated in Belgium in 2005 5 (the alleles showed 100% nucleotide identity except for one nucleotide in the ardA locus). This bla TEM-52 plasmid is reported to be widely disseminated among different Salmonella serovars from poultry and humans in Belgium and France. 6 The bla TEM-20 plasmids were large (.100 kb) and showed profiles that seemed to be similar when comparing the PstI and EcoRI restriction patterns with published restrictions patterns of the bla TEM-52 plasmid. 5 -7 The bla TEM-52 gene has been identified within a Tn3 transposon derivative on the plasmid described earlier (accession number EF141186). 6 Primers were designed in order to amplify and sequence a similar region (6.6 kb) in E. coli 1248 and in Salmonella Paratyphi B dT þ . A Tn3-related transposon, with 100% identical nucleotide sequence, was detected in both strains. Only one amino acid, E104K, distinguishes TEM-20 from TEM-52. Comparison between the bla TEM-20 sequence and the bla TEM-52 sequence revealed only one nucleotide difference ( producing amino acid alteration E104K). Five additional nucleotide differences were found when the remaining parts of the DNA region were aligned, indicating a close relationship between the bla TEM-20 and bla TEM-52 transposons. In conclusion, two closely related plasmid scaffolds carrying identical transposons were identified, associated with bla TEM-20 in E. coli from Norway and in Salmonella Paratyphi B dT þ from the Netherlands, and with bla TEM-52 in Salmonella from Belgium and France. Detection of an extended-spectrum b-lactamase (ESBL)-positive E. coli from livestock in Norway was unexpected as there are no commercial preparations containing cephalosporins licensed for veterinary use. An interview with the farmer confirmed that there had been no use of cephalosporins for animals or humans at the farm. The strain, or plasmid, might have been part of bacterial flora of animals taken to Norway for breeding purposes.
The bla TEM-20 plasmid conferring low-level resistance to cephalosporins may represent a challenge with regard to detection of ESBL-positive isolates. The plasmids might also have the potential to develop into variants conferring higher levels of resistance as only one mutation may contribute to a change in the phenotype.
Accession number
The nucleotide sequence determined is available under accession number EU527189.
